IMDXInsight Molecular Diagnostics Inc. Common Stock

NAS · US · Healthcare · Diagnostics & Research · imdxinc.com

4.340USD-0.91%Mkt Cap: 142.02M $P/E: —3d ago

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap142.02M $

Enterprise Value125.58M $

Revenue (TTM)1.67M $

Gross Profit2.30M $

Net Income (TTM)-50.22M $

Revenue/Share0.0490 USD

Last Price4.340 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees55

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-5.12

PEG—

EV/EBITDA-3.64

EV/Revenue75.20

P/S84.26

P/B-6.58

EPS (TTM)-1.49

EPS (Forward)-0.84

52W Range

2.33033% of range8.510

52W High8.510 USD

52W Low2.330 USD

Profitability

Gross Margin56.67%

Oper. Margin-3815.06%

EBITDA Margin0.00%

Profit Margin-1238.52%

ROE159.62%

ROA-194.99%

Growth

Revenue Growth-53.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-22.18M $

CapEx (TTM)3.19M $

FCF Margin-1125.12%

FCF Yield-13.23%

Net Debt-15.13M $

Net Debt/EBITDA0.44

Balance Sheet

Debt/Equity-0.11

Current Ratio2.00

Quick Ratio1.75

Book Value/Sh-0.6530 USD

Cash/Share0.5430 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJul 25, 2023

Analyst Consensus

Rating2.3 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)8.333 USD

Upside (mean)+92.0%

Target Range4.000 USD – 12.00 USD

$4.000+92.0% to mean$12.00

# Analysts3

Ownership

Shares Out.32.72M

Float10.40M

Insiders21.00%

Institutions56.43%

Short Interest

Short Ratio5.8d

Short % Float6.64%

Short % Out.3.29%

Shares Short1.07M

Short (prev mo.)1.01M

Technical

SMA 504.966 (-12.6%)

SMA 2005.397 (-19.6%)

Beta1.82

S&P 52W Chg18.16%

Avg Vol (30d)207.38K

Avg Vol (10d)309.47K

Technical Indicators

RSI (14)43.8

MACD-0.2034

MACD Signal-0.1819

MACD Hist.-0.0215

BB Upper5.269 USD

BB Middle4.606 USD

BB Lower3.944 USD

BB Width28.77%

ATR (14)0.4031 USD

Vol Ratio (20d)0.18x